Active Filter(s):
Details:
CLAR-121 is a proprietary combination of testosterone (T) (natural ligand for the androgen receptor; AR) and anastrozole (inhibitor of T conversion to estradiol) delivered by a subcutaneous implant for treatment of AR-mediated breast disease that predominantly affects women.
Lead Product(s): Testosterone,Anastrozole
Therapeutic Area: Immunology Product Name: CLAR-121
Highest Development Status: N/A Product Type: Small molecule
Partner/Sponsor/Collaborator: Clarus Therapeutics
Deal Size: $11.2 million Upfront Cash: $0.5 million
Deal Type: Licensing Agreement May 25, 2021